dapagliflozin/sitagliptin (SID1903)
/ SK Bio
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
October 26, 2022
A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
(clinicaltrials.gov)
- P1 | N=45 | Completed | Sponsor: SK Chemicals Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion
October 26, 2022
A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
(clinicaltrials.gov)
- P1 | N=51 | Completed | Sponsor: SK Chemicals Co., Ltd. | Recruiting ➔ Completed
Trial completion
July 12, 2022
A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
(clinicaltrials.gov)
- P1 | N=50 | Recruiting | Sponsor: SK Chemicals Co., Ltd.
New P1 trial
1 to 3
Of
3
Go to page
1